Building the foundations of digital health literacyFrom policy to grassroots levels, there’s a heavy emphasis on the value of digital health throughout healthcare systems. Share XBuilding the foundations of digital health literacyhttps://pharmaphorum.com/views-analysis-digital/building-foundations-digital-health-literacy/
UCB’s James Musick on embracing digital therapeuticsDigital has rapidly taken over the pharma industry, but many still don’t fully understand how to harness it. Share XUCB’s James Musick on embracing digital therapeuticshttps://pharmaphorum.com/views-analysis-digital/ucbs-james-musick-on-embracing-digital-therapeutics/
Listen and support: How to conduct a patient-centric clinical studyClinical trial sponsors understand the value of patient-centric studies, but success relies on a time-consuming paradigm shift and Share XListen and support: How to conduct a patient-centric clinical studyhttps://pharmaphorum.com/r-d/views-analysis-r-d/listen-and-support-how-to-conduct-a-patient-centric-clinical-study/
Supporting the next generation of digital pharmaciesThis year marks the 20th anniversary of the UK’s first internet pharmacy and the sector has steadily increased, Share XSupporting the next generation of digital pharmacieshttps://pharmaphorum.com/views-analysis-digital/supporting-the-next-generation-of-digital-pharmacies/
Millendo’s Julia Owens on leadership in rare diseasesRare disease specialists Millendo Therapeutics are hoping their drug livoletide will become the first treatment for Prader-Willi syndrome. Share XMillendo’s Julia Owens on leadership in rare diseaseshttps://pharmaphorum.com/r-d/views-analysis-r-d/millendo-julia-owens-leadership-rare-diseases/
How digital is reversing fortunes in R&DA new report lays out the ways digital transformation could reverse the trend of declining ROI in pharma Share XHow digital is reversing fortunes in R&Dhttps://pharmaphorum.com/views-analysis-digital/digital-reversing-fortunes-rd/
Changing how we talk about clinical trialsMultiple sclerosis (MS) patient Elizabeth Kinder tells us why she participated in a clinical trial and why the Share XChanging how we talk about clinical trialshttps://pharmaphorum.com/views-analysis-patients/changing-talk-clinical-trials-ms/
Customer experience in pharma: Getting the journey rightAs part of a series of interviews in partnership with Indegene focusing on the customer experience in pharma, Share XCustomer experience in pharma: Getting the journey righthttps://pharmaphorum.com/views-analysis-sales-marketing/customer-experience-in-pharma-getting-the-journey-right/
Helsinn’s Riccardo Braglia on the patient perspective in cancer careSwiss cancer care company Helsinn has become unique in the industry by remaining a family business over three Share XHelsinn’s Riccardo Braglia on the patient perspective in cancer carehttps://pharmaphorum.com/views-analysis-oncology/helsinns-riccardo-braglia-patient-perspective-cancer-care/
